Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Shopify Inc. (SHOP) vs Twist Bioscience Corp (TWST) Price & Performance

Shopify Inc.Trade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Shopify Inc. vs Twist Bioscience Corp — how do they compare? Shopify Inc. trades at $151.57 (market cap $196.35B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Shopify Inc. is far larger — about 25.4× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Shopify Inc. nearer its low. Which is the better fit depends on your goals.

SHOPTWST
Market Cap
$196.35B$7.72B
Sector
TechnologyHealth
52-Week High
$179.01$124.88
52-Week Low
$95.40$24.16
Enterprise Value
$191.59B$7.65B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Shopify Inc.

Shopify (SHOP) trades at $155.18, up 2.38% today, following strong Q2 2026 earnings beats. The stock exhibits a bullish technical trend with support at $151 and resistance at $158. Revenue growth remains robust, with 2025 revenue reaching $11.56B, though valuation multiples like a P/E of 103.11 are elevated. Positive analyst sentiment is driven by AI commerce integration and expanding gross merchandise volume.

Outlook is positive given earnings momentum and AI-driven growth, but high valuation and competitive e-commerce pressures pose risks. The consensus price target of $166.39 suggests modest upside, supported by 65.62% of analysts rating it Buy. Investors should weigh growth prospects against premium pricing.

Twist Bioscience Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Shopify Inc.

Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.

Read more on SHOP

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST